Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no...

43
Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Transcript of Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no...

Page 1: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Should You Be On A Statin Drug?Making Sense Of The New Cholesterol Guidelines

Robert DuBroff (no financial disclosures)

Page 2: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Don’t shoot the messenger

Page 3: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Atherothrombosis Causes Heart Attacks

Page 4: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Causes of Death in the United States

0

100

200

300

400

500

600

700

800

900

1,000

Deat

hs (t

hous

ands

)

CHD Cancer Accidents HIV/AIDS

959.2

544.7

93.832.7

American Heart Association. Heart and Stroke Statistical Update.

Page 5: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

©2011 American Heart Association, Inc. All rights reserved.

Roger VL et al. Published online in Circulation Dec. 15, 2011

Deaths due to diseases of the heart (United States: 1900–2008)

1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 20080

200

400

600

800

1,000

Years

Dea

ths

in T

ho

usa

nd

s

Source: National Center for Health Statistics.

Page 6: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Deaths due to diseases of the heart (United States: 1900–2008)

1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 20080

200

400

600

800

1,000

Years

Dea

ths

in T

ho

usa

nd

s

Page 7: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Roger VL et al. Published online in Circulation Dec. 15, 2011

Deaths due to diseases of the heart (United States: 1900–2008)

1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 20080

200

400

600

800

1,000

Years

Dea

ths

in T

ho

usa

nd

s

MMWR September 25, 2009 / 58(37);1045

Page 8: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Deaths due to diseases of the heart (United States: 1900–2008)

1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 20080

200

400

600

800

1,000

Years

Dea

ths

in T

ho

usa

nd

s

Page 9: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Deaths due to diseases of the heart (United States: 1900–2008)

1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 20080

200

400

600

800

1,000

Years

Dea

ths

in T

ho

usa

nd

s

Page 10: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Rates of per Capita Cigarette Consumption and Age-Adjusted Rates of Death from Heart Disease in California Relative to Rates in the Rest of the United States and Predicted Rates If the Tobacco-Control Program Had Not

Been Instituted in 1989 and If It Had Not Been Cut Back in 1992.

Fichtenberg CM, Glantz SA. N Engl J Med 2000;343:1772-1777.

Page 11: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Is Cholesterol The Right Target?

• Is cholesterol a good risk factor?• Does lowering cholesterol by diet reduce CV

mortality rates?• Does lowering LDL cholesterol by non-statin

drugs reduce CV mortality rates?• Does lowering LDL cholesterol by statin drugs

reduce CV mortality?

Page 12: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Ideal Risk Factor

Page 13: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Framingham Heart Study WILLIAM B. KANNEL, M.D., M.P.H.; WILLIAM P. CASTELLI, M.D.; TAVIA GORDON, Cholesterol in the Prediction of Atherosclerotic Disease: New

Perspectives Based on the Framingham Study. Ann Intern Med. 1979; 90

Page 14: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

The Women’s Health Initiative Randomized Controlled Dietary

Modification Trial

• 48,835 women age 50-79 years• Intervention - low fat diet (<20% of calories from

fat), fruits & vegetables 5 servings/day, grains 6 servings/day

• Control group• After 8.1 years no reduction in stroke, CHD, or CVD• LDL cholesterol decreased 133 to 123 mg/dlJAMA 2006, vol 295, no 6, 655-666

Page 15: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk:

A Systematic Review and Meta-analysisAnn Intern Med 2014; 160: 398-406

• Meta-analysis of 72 studies of reduced dietary saturated fat and CV outcomes

• Conclusion: Current evidence does not clearly support cardiovascular guidelines that encourage high consumption of polyunsaturated fatty acids and low consumption of total saturated fats.

Page 16: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Lyon Diet Heart Study: Cumulative Survivalde Lorgeril M et al. Lancet.

1994;343:1454-1459.

Page 17: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

www.oldwayspt.org

Page 18: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Dietary Prevention of Coronary Heart Disease: The Lyon Diet Heart Study

Circulation. 1999;99:733-735

• Simple dietary changes achieved greater reductions in all cause mortality than any statin trial.

• Unprecedented reductions in CHD was not associated with any change in cholesterol levels.

• Patient adherence was outstanding and no adverse side effects reported.

• Promotion of the Mediterranean diet would lead to dramatic cost savings over traditionally employed drugs, devices, and surgery.

Page 19: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Comparing DietsDASH (Dietary Approaches to

Stop Hypertension)

• Fruits, vegetables, nuts, legumes, whole grains

• Low sodium• Low fat (<27% calories)• Some red meat• No wine• Lowers BP and cholesterol

at 8 weeks• No RCT mortality studies

Mediterranean

• Fruits, vegetables, nuts, legumes, whole grains

• No sodium restriction• Higher fat – fish, olive oil• Replace red meat with

seafood• Red wine• Minor effect on BP and

cholesterol but dramatic reduction in DM

• Dramatic mortality reduction in RCTs at up to 10 years

Page 20: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Over a dozen studies involving > 1.5 million participants consistently show adherence to a Mediterranean diet protects again premature cardiovascular and neoplastic diseases

Page 21: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Drugs Which Reduce Cholesterol

• Bile acid sequestrants• Niacin• Fibrates• Cholesterol absorption inhibitors• Statins

Page 22: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Problems with Statin Trials

1. Combined clinical endpoints instead of mortality

2. Premature trial terminations3. Oversight by the pharmaceutical

company sponsor4. Post-2005 studies don’t show

mortality benefit

Page 23: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Statin Trials in High Risk Populations

• Elderly – PROSPER• Heart failure – CORONA, GISSI-HF• Renal failure – 4D, AURORA, SHARP• PVD – Cochrane meta-analysis (18 studies)• ACS – Cochrane meta-analysis (18 studies)• High CCS – St. Francis Heart• Diabetes – CARDS, 4D, ASPEN

Page 24: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Cholesterol Guidelines

Page 25: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Common Elements of All Cholesterol Guidelines

1. Lifestyle managementa) Smoking cessationb) Regular exercisec) Healthy diet

2. Primary prevention statin use3. Secondary prevention statin use4. Intensity of treatment5. Non-statin medications

Page 26: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Bumps in the Road to New Cholesterol Guidelines

Dr. Steven Nissen, a Cleveland Clinic cardiologist, said of a medical committee’s guidelines, “There will be a large backlash.”

November 25, 2013

Page 27: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Criticism of the new guidelines

• The risk calculator may overestimate risk.• Out of 46 recommendations, 20 were based only

on expert opinion.• Too many people will be put on statins.• Numerous professional organizations do not

endorse the new guidelines.• Conflict of interest: six out of the 15 authors

reported having recent or current ties to manufacturers of statin drugs.

• Lack of LDL targets may discourage desired patient behavior

Page 28: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Four Statin Eligible Patient Groups

• Individuals with clinical ASCVD• Individuals with primary elevations of LDL–C ≥190

mg/dL.• Individuals 40 to 75 years of age with diabetes and

LDL–C 70 to 189 mg/dL without clinical ASCVD• Individuals without clinical ASCVD or diabetes who

are 40 to 75 years of age with LDL–C 70 to 189 mg/dL and have an estimated 10-year ASCVD risk of 7.5% or higher.

Page 29: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Statin Intensity

HIGH

• DM, age 40-75 years with ASCVD

• ASCVD, age < 75 years• LDL > 190, age > 21 years

MODERATE

• DM, age 40-75 years, no ASCVD

• ASCVD, age > 75 years• LDL 70-189, risk > 7.5%/10

years

Page 30: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Non-Statin Drug Therapy

Bile acid sequestrantsNiacinFibratesCholesterol absorption inhibitors

Not recommended, use is optional

Page 31: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)
Page 32: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

AgeGender

Total CholesterolHDL Cholesterol

SmokingSystolic BP

Hypertensive medshttp://my.americanheart.org/cvriskcalculator

Page 33: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Estimating Risk of ASCVD

For Intermediate Risk < 7.5%/10 yrOptional use of tools to refine risk

•Family history of premature ASCVD•High-sensitivity CRP•Coronary artery calcium score•Ankle brachial index

Page 34: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Primary PreventionHow to Predict Cardiovascular Events

Use Risk Factors• Framingham Risk Score• Pooled Cohort Equations

Look for atherosclerosis

Page 35: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Paradigm Shift in Risk Prediction Atherosclerosis Versus Risk Factors

Page 36: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)
Page 37: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Prediction of MI/SCD in Asymptomatic Patients:EBTRaggi et al AHJ 2001;141:193-199

0.36 0.51 0.710.99

1.38

1.922.64

3.62

4.9

6.54

0

1

2

3

4

5

6

7

0 10 20 30 40 50 60 70 80 90

Percentile Rank for Baseline EBCT Calcium Score

676 initially asymptomatic patients 32+7 months f/u

Annual Absolute Risk

Prediction of MI/SCD in Asymptomatic Patients:EBTRaggi et al AHJ 2001;141:193-199

Page 38: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Atherosclerosis Test

Very Low Risk3

Negative Test• CCS =0• CIMT<50th percentile

LowerRisk

ModerateRisk

Positive Test• CCS ≥1• CIMT 50th percentile or Carotid Plaque

ModeratelyHigh Risk

HighRisk

VeryHigh Risk

No Risk Factors5 + Risk Factors • CCS <100 & <75th% • CIMT <1mm & <75th%

& No Carotid Plaque

• Coronary Calcium Score (CCS)or

• Carotid IMT (CIMT) & Carotid Plaque4

• CCS 100-399 or >75th%• CIMT 1mm or >75th%

or <50% Stenotic Plaque

• CCS >100 & >90th%or CCS 400

• 50% Stenotic Plaque6

IndividualizedIndividualizedIndividualized5-10 years5-10 yearsRe-test Interval

<70 mg/dl<100 mg/dl<70 Optional

<130 mg/dl<100 Optional

<130 mg/dl<160 mg/dlLDLTarget

All >75y receive unconditional treatment2

Apparently Healthy Population Men>45y Women>55y1

ExitExit

Myocardial IschemiaTest

NoAngiography

Follow Existing Guidelines

Yes

The 1st S .H .A .P .E . GuidelineTowards the National Screening for Heart Attack Prevention and Education (SHAPE) Program

Step 1

Step 2

Step 3Optional

CRP>4mg

ABI<0.9

Page 39: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

A statin a day keeps the doctor away:comparative proverb assessment modelling

study

9400 lives saved if every UK citizen over age 50 took a daily statin

BMJ 2013;347:f7267 (Published 17 December 2013)

8500 lives saved if every UK citizen over age 50 ate an apple a day

Page 40: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Final Exam

By following a healthy lifestyle and diet one may potentially reduce the risk of sudden cardiac death by:a. 20%b. 44%c. 68%d. 92%

Page 41: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Adherence to a Low-Risk, Healthy Lifestyle and Risk of Sudden Cardiac Death Among Women

JAMA 2011;306(1):62-69

Page 42: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

Final Thoughts

• Will the new guidelines result in too many people taking a statin drug?

• What is the best way to identify high risk patients for primary prevention?

• What intensity of statin should I use?• Should I take patients off of non-statin lipid

therapies?• Is there a better option than statins for CVD

prevention?

Page 43: Should You Be On A Statin Drug? Making Sense Of The New Cholesterol Guidelines Robert DuBroff (no financial disclosures)

“Heads you take a statin drug, tails you become a pescatarian.”